Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

PaperCitations, authors & open-access status

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 109 citations, 2023 year and hybrid oa status.

109
Citations
2023
Year
hybrid
OA Status

Related on ScholarIQ

Pierre Combe
Author
Journal of Clinical Oncology
Journal
Ovarian cancer diagnosis and treatment
Topic
Ovarian cancer diagnosis and treatment
Topic
PARP inhibition in cancer therapy
Topic
Cancer Immunotherapy and Biomarkers
Topic
470M+ articles · free account